Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

ClinicalTrials.gov ID: NCT00094653

Public ClinicalTrials.gov record NCT00094653. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multicenter Study Comparing MDX-010 Monotherapy, MDX-010 in Combination With a Melanoma Peptide Vaccine, and Melanoma Vaccine Monotherapy in HLA-A2*0201-Positive Patients With Previously Treated Unresectable Stage III or IV Melanoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and efficacy of MDX-010 (ipilimumab, BMS-734016) (anti-CTLA4) in combination with MDX-1379 (gp100, BMS-734019) in patients with previously treated, unresectable Stage III or IV melanoma. Survival time will be evaluated, as well as patient responses and time to disease progression. Eligible patients are those who in response to a single regimen containing interleukin-2 (IL-2), dacarbazine, and/or temozolomide, have 1) relapsed following an objective response (partial response/complete response \[PR/CR\]); 2) failed to demonstrate an objective response (PR/CR); or 3) could not tolerate such a regimen due to unacceptable toxicity. Patients will be randomized into one of three groups, and will receive one of the following treatments: MDX-010 alone, MDX-1379 alone, or MDX-010 in combination with MDX-1379.

Study identification

NCT ID
NCT00094653
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,783 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2004 (Type not available)
Primary completion
Aug 2009 (Actual)
Completion
Oct 2009 (Actual)
Last update posted
Jul 11, 2011

2004 – 2009

United States locations

U.S. sites
110
U.S. states
27
U.S. cities
81
Facility City State ZIP Site status
Arizona Cancer Center Tucson Arizona 85724 —
University Medical Center Tucson Arizona 85724 —
City of Hope National Medical Center Duarte California 91010 —
San Diego Cancer Center Encinitas California 92024 —
La Jolla Hematology and Oncology Medical Group La Jolla California 92037 —
Scripps Cancer Center La Jolla California 92037 —
Moores UCSD Cancer Center La Jolla California 92093 —
Pacific Shores Medical Group Long Beach California 90813 —
Cancer Institute Medical Group, Inc Los Angeles California 90025 —
The Angeles Clinic and Research Institute Los Angeles California 90025 —
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 —
North County Oncology Medical Clinical, Inc. Oceanside California 92056 —
City of Hope Medical Group Pasadena California 91105 —
University of California, San Diego San Diego California 92103 —
St. Mary's Medical Center - Northern California Melanoma Center San Francisco California 94109 —
Cancer Institute Medical Group, Inc Santa Monica California 90404 —
San Diego Cancer Center Vista California 92081 —
Anschutz Cancer Pavilion Aurora Colorado 80010 —
Rocky Mountain Cancer Centers Aurora Colorado 80012 —
University of Colorado Health Sciences Center Aurora Colorado 80045 —
Rocky Mountain Cancer Centers Boulder Colorado 80304 —
Rocky Mountain Cancer Centers Colorado Springs Colorado 80909 —
Rocky Mountain Cancer Centers Denver Colorado 80218 —
University of Colorado Hospital Denver Colorado 80262 —
Rocky Mountain Cancer Centers Lakewood Colorado 80228 —
Rocky Mountain Cancer Centers Littleton Colorado 80120 —
Rocky Mountain Cancer Centers Lone Tree Colorado 80124 —
Rocky Mountain Cancer Centers Longmont Colorado 80501 —
Yale University School of Medicine - Oncology Outpatient Clinic New Haven Connecticut 06520 —
Mount Sinai Comprehensive Cancer Center at Aventura Aventura Florida 33180 —
Memorial Regional Cancer Center Hollywood Florida 33021 —
Shands Jacksonville Jacksonville Florida 32209 —
University of Florida/Jacksonville Faculty Clinic Jacksonville Florida 32209 —
Jackson Memorial Hospital & Clinics Miami Florida 33136 —
University of Miami Hospital & Clinics Miami Florida 33136 —
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140 —
Mount Sinai Medical Center Miami Beach Florida 33140 —
M.D. Anderson Cancer Center Orlando Orlando Florida 32806 —
Palm Beach Cancer Institute Palm Beach Gardens Florida 33410 —
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 —
Palm Beach Cancer Institute Wellington Florida 33414 —
Palm Beach Cancer Institute West Palm Beach Florida 33401 —
Emory University Hospital-Winship Cancer Institute Atlanta Georgia 30322 —
Cancer Care Specialists of Central IL Decatur Illinois 62526 —
Decatur Memorial Hospital Decatur Illinois 62526 —
Cancer Care Specialists of Central IL Effingham Illinois 62401 —
Cardinal Bernardin Cancer Center, Loyola Unv. Med. Ctr. Maywood Illinois 60153 —
Center for Cancer Care at Goshen Health System Goshen Indiana 46526 —
Indiana Oncology Hematology Consultants North Indianapolis Indiana 46202 —
American Health Network of IN, LLC Indianapolis Indiana 46237 —
Indiana Oncology Hematology South Indianapolis Indiana 46237 —
Indiana Oncology Hematology Consutants of Noblesville Noblesville Indiana 46060 —
Central Baptist Hospital Lexington Kentucky 40503 —
James Graham Brown Cancer Center Louisville Kentucky 40202 —
Norton Hospital Louisville Kentucky 40202 —
University of Louisville Hospital Louisville Kentucky 40202 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 —
Franklin Square Hospital Center Baltimore Maryland 21237 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Lutherville Maryland 21093 —
Beth Isreal Dec Medical Center Boston Massachusetts 02115 —
Brigham and Womens Hospital Boston Massachusetts 02115 —
Dana Farber Cancer Institute Boston Massachusetts 02115 —
Henry Ford Medical Center Dearborn Michigan 48126 —
Henry Ford Hospital Detroit Michigan 48202 —
Henry Ford Medical Center- West Bloomfield West Bloomfield Michigan 48322 —
Humphrey Cancer Center Coon Rapids Minnesota 55433 —
Humphrey Cancer Center Fridley Minnesota 55432 —
Hubert H Humphrey Cancer Center Robbinsdale Minnesota 55422 —
Family Cancer Center Olive Branch Mississippi 38654 —
Ellis Fischel Cancer Center Columbia Missouri 65203 —
St. Joseph Oncology, Inc Saint Joseph Missouri 64507 —
Barnes Jewish Hospital St Louis Missouri 63110 —
Washington Unv. School of Med./ Siteman Cancer Center St Louis Missouri 63110 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
The Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 —
Hematology-Oncology Associates of Northern NJ, PA Morristown New Jersey 07962 —
Robert Wood Johnson University Hospital New Brunswick New Jersey 08901 —
The Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
Overlook Oncology Center Summit New Jersey 07901 —
New Mexico Oncology Hematology Consultants, Ltd. Albuquerque New Mexico 87109 —
Hematology-Oncology Associates of CNY East Syracuse New York 13057 —
Memorial Sloan Kettering Cancer Center New York New York 10021 —
Columbia University Medical Center, Irving Center for Clinical Research New York New York 10032 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7050 —
The Christ Hospital Cancer Center Cincinnati Ohio 45219 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Providence Portland Medical Center Portland Oregon 97213 —
The Oregon Clinical Portland Oregon 97213 —
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Thomas Jefferson University Hosptital Philadelphia Pennsylvania 19107 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Hillman Cancer Research Pavilion Pittsburgh Pennsylvania 15213 —
Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 —
Cancer Centers of the Carolinas Easley South Carolina 29640 —
Cancer Centers of the Carolinas Greenville South Carolina 29615 —
Cancer Centers of the Carolinas Seneca South Carolina 29672 —
Cancer Centers of the Carolinas Spartanburg South Carolina 29307 —
Family Cancer Center Bartlett Tennessee 38133 —
Family Cancer Center Collierville Tennessee 38017 —
Family Cancer Center Memphis Tennessee 38119 —
The West Clinic Memphis Tennessee 38120 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Arlington Cancer Center Arlington Texas 76012 —
Center for Oncology Research and Treatment Dallas Texas 75230 —
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410 —
Center for Oncology Research and Treatment Richardson Texas 75080 —
Huntsman Cancer Institute Salt Lake City Utah 84112-5550 —
Huntsman Cancer Institute Salt Lake City Utah 84112 —
Fletcher Allen Health Care Burlington Vermont 05405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00094653, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2011 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00094653 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →